These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20572132)

  • 1. Gadolinium-labeled quantum dots for molecular magnetic resonance imaging: R1 versus R2 mapping.
    Oostendorp M; Douma K; Hackeng TM; Post MJ; van Zandvoort MA; Backes WH
    Magn Reson Med; 2010 Jul; 64(1):291-8. PubMed ID: 20572132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots.
    Oostendorp M; Douma K; Hackeng TM; Dirksen A; Post MJ; van Zandvoort MA; Backes WH
    Cancer Res; 2008 Sep; 68(18):7676-83. PubMed ID: 18794157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid functionalized gadolinium-doped carbon dots as fluorescence / magnetic resonance imaging contrast agent for targeted imaging of liver cancer.
    Du J; Zhou S; Ma Y; Wei Y; Li Q; Huang H; Chen L; Yang Y; Yu S
    Colloids Surf B Biointerfaces; 2024 Feb; 234():113721. PubMed ID: 38176338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-size dependent water proton relaxivities in ultrasmall gadolinium oxide nanoparticles and in vivo T1 MR images in a 1.5 T MR field.
    Kim CR; Baeck JS; Chang Y; Bae JE; Chae KS; Lee GH
    Phys Chem Chem Phys; 2014 Oct; 16(37):19866-73. PubMed ID: 25123195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of contrast agents in oncological imaging: magnetic resonance imaging.
    Morana G; Cugini C; Scatto G; Zanato R; Fusaro M; Dorigo A
    Cancer Imaging; 2013 Sep; 13(3):350-9. PubMed ID: 24060901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
    Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
    Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the strong field dependence and nonlinear response to gadolinium contrast agent of proton transverse relaxation rates in dairy cream.
    Mulkern RV; Hung YP; Ababneh Z; Maier SE; Packard AB; Uluer MC; Kacher DF; Gambarota G; Voss S
    Magn Reson Imaging; 2005 Jul; 23(6):757-64. PubMed ID: 16198831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of contrast agents targeted to the tumor vasculature in molecular magnetic resonance imaging.
    Oostendorp M; Douma K; Hackeng TM; van Zandvoort MA; Post MJ; Backes WH
    Contrast Media Mol Imaging; 2010; 5(1):9-17. PubMed ID: 20101742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-enhanced gadolinium-doped zinc oxide quantum dots for magnetic resonance and fluorescence imaging.
    Liu Y; Ai K; Yuan Q; Lu L
    Biomaterials; 2011 Feb; 32(4):1185-92. PubMed ID: 21055806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.
    Surányi P; Kiss P; Ruzsics B; Brott BC; Simor T; Elgavish GA
    Magn Reson Imaging; 2007 Jun; 25(5):641-51. PubMed ID: 17540275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.
    Cheng W; Ping Y; Zhang Y; Chuang KH; Liu Y
    J Healthc Eng; 2013; 4(1):23-45. PubMed ID: 23502248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile synthesis of Silicon quantum dot-Gadolinium: A potential fluorescent/T1-T2 multimodal imaging agent.
    Xiao F; Xiao Y; Chen F; Liu X; Lin C; Chen J; Wu Y
    Talanta; 2019 Jul; 199():336-346. PubMed ID: 30952268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography?
    Yu G; Yamashita M; Aoshima K; Takahashi M; Oshikawa T; Takayanagi H; Laurent S; Burtea C; Vander Elst L; Muller RN
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2246-9. PubMed ID: 17303417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo MRI and ex vivo quantification of iron and Kupffer cells demonstrate residual phagocytic activity in mouse liver after a gadolinium chloride injection.
    Fabre M; Leroy-Willig A; Denis CV; Ba N; Schoëvaërt D; Guettier C; Geldwerth-Feniger D
    Biochimie; 2010 Oct; 92(10):1343-53. PubMed ID: 20600563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DTTA-ligated uridine-quantum dot conjugate as a bimodal contrast agent for cellular imaging.
    Park J; Bhuniya S; Lee H; Noh YW; Lim YT; Jung JH; Hong KS; Kim JS
    Chem Commun (Camb); 2012 Mar; 48(26):3218-20. PubMed ID: 22349268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications.
    Helm L
    Future Med Chem; 2010 Mar; 2(3):385-96. PubMed ID: 21426173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging.
    Bridot JL; Faure AC; Laurent S; Rivière C; Billotey C; Hiba B; Janier M; Josserand V; Coll JL; Elst LV; Muller R; Roux S; Perriat P; Tillement O
    J Am Chem Soc; 2007 Apr; 129(16):5076-84. PubMed ID: 17397154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.